Interestingly, several studies have shown that STAT3 is constitutively activated in invasive BCs, but not benign tumors, indicating that STAT3 is mainly involved in tumor progression and metastasis, rather than tumor initiation (Watson and Miller, 1995; Ranger et al., 2009; Resemann et al., 2014). This evidence concerns the gene STAT3 and neoplasm.